Examining the Circadian Timing Effects of the Hypotensive Response to Exercise

This fully counterbalanced, within-subject, randomized crossover trial will examine the time-of-day dependent hypotensive effect of exercise in adults aged 18-39 years with elevated blood pressure or stage 1 hypertension. To examine this, participants will complete an assessment of dim-light melatonin onset (DLMO), the gold standard assessment of individual circadian phase, which will be used to subsequently prescribe three exercise sessions in the morning (10 hours after DLMO), afternoon (15 hours after DLMO), and evening (20 hours after DLMO) with 24-hour blood pressure assessment before and after each exercise sessions.

Inclusion criteria

• 18-39 Years old
• Resting blood pressure greater than or equal to 120/80 mmHg or less than 140/90 mmHg

Exclusion criteria

• Diagnosis or history of chronic or autoimmune disease (i.e., cardiovascular, metabolic, renal, endocrine, cancer)
• Diagnosis or history of sleep disorder (i.e., obstructive sleep apnea, insomnia, restless leg syndrome)
• Alcohol or drug dependence
• Elevated risk for sleep disorders
• Elevated risk for clinical depression
• Normotensive (blood pressure less than 120/80 mmHg) or stage 2+ hypertension (blood pressure greater than or equal to 140/90 mmHg)
• Body mass index less than 18.5 or greater than 35 kg/m2
• Self-reported use of sleep medications/supplements (e.g., melatonin)
• Self-reported use of medications influencing vascular physiology (e.g., antihypertensive medications, weight loss medications)
• Highly physically active (greater than or equal to 300 minutes moderate-to-vigorous physical activity per week)
• Currently pregnant or breastfeeding
• Current tobacco use (greater than or equal to 1 cigarette in the past month)
• Nighttime or rotating shift work within the last 3 months
• Contraindications to aerobic exercise